Ligand profile
AM3
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04425 — Aryl-phospho-beta-D-glucosidase bglC
Identifiers
Database identifiers and provenance.
- Ligand ID
AM3- PDB
2wc3- UniProt (similar protein)
Q08638- Target protein
- KP13_04425
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 105.8
- −1 ≤ LogP ≤ 5 -0.18
- MW ≤ 500 Da 316.4
- LogP ≤ 5 -0.18
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 105.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCC/N=C\1/N2[C@H](CO1)[C@@H]([C@@H]([C@H]([C@@H]2O)O)O)OCCCCCCCC/N=C\1/N2[C@H](CO1)[C@@H]([C@@H]([C@H]([C@@H]2O)O)O)O
InChI=1S/C15H28N2O5/c1-2-3-4-5-6-7-8-16-15-17-10(9-22-15)11(18)12(19)13(20)14(17)21/h10-14,18-21H,2-9H2,1H3/b16-15-/t10-,11+,12+,13-,14+/m1/s1InChI=1S/C15H28N2O5/c1-2-3-4-5-6-7-8-16-15-17-10(9-22-15)11(18)12(19)13(20)14(17)21/h10-14,18-21H,2-9H2,1H3/b16-15-/t10-,11+,12+,13-,14+/m1/s1
QJILQIWQVOAQBB-FOERHGQSSA-NQJILQIWQVOAQBB-FOERHGQSSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00232
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AM3 →
- PDB RCSB structure 2wc3 →
- UniProt UniProt Q08638 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AM3”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04425.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 5
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).